Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
599 studies found for:    Open Studies | "Carcinoid Tumor"
Show Display Options
Rank Status Study
1 Not yet recruiting A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Condition: Carcinoid Tumors
Interventions: Drug: Ramucirumab;   Drug: Somatostatin Analog
2 Recruiting A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors
Condition: Carcinoid Tumors
Interventions: Drug: Lanreotide;   Drug: Placebo (for sunitinib);   Drug: Sunitinib
3 Available Expanded Access Protocol for Therapeutic Use of 177Lu-DOTA0-Tyr3-Octreotate in Patients With Inoperable, Somatostatin Receptor Positive, Midgut Carcinoid Tumors, Progressive Under Somatostatin Analogue Therapy
Condition: Midgut Carcinoid Tumor
Intervention: Drug: 177Lu-DOTA0-Tyr3-Octreotate
4 Recruiting Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors
Condition: Carcinoid Tumor
Intervention: Drug: Ziv-aflibercept
5 Recruiting Natural History of Familial Carcinoid Tumor
Condition: Carcinoid
Intervention:
6 Recruiting SwissNET - a Registry for Neuroendocrine Tumours in Switzerland
Conditions: Neuroendocrine Tumors;   Carcinoid Tumor
Intervention:
7 Recruiting 68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)
Conditions: Neuroendocrine Tumors;   Carcinoid Tumors
Intervention: Device: 68Ga-DOTATOC PET
8 Recruiting Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: Lutetium-177 Octreotate
9 Not yet recruiting Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors
Condition: Small-intestine Neuroendocrine Tumors (Carcinoid Tumors)
Intervention: Biological: blood sample withdrawn
10 Recruiting Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: Recombinant anti-tumor and anti-virus protein for injection (Novaferon)
11 Recruiting Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study
Condition: Neuroendocrine Tumor
Intervention: Other: Videoconsultation
12 Recruiting Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
Conditions: Carcinoid Tumors;   Pancreatic NET
Intervention: Drug: Ibrutinib
13 Recruiting Best Therapy for Patients With Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention:
14 Recruiting A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors
Condition: Well-differentiated Neuroendocrine Tumors
Intervention: Drug: Metformin
15 Recruiting Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Conditions: Carcinoid Tumor;   Metastatic Carcinoid Tumor;   Neuroendocrine Neoplasm
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nintedanib;   Other: Pharmacological Study;   Other: Quality-of-Life Assessment
16 Recruiting Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor
Condition: Neuroendocrine Tumor
Interventions: Other: Web-based tailored information and support system;   Other: Standard care
17 Recruiting Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Other: 99m Tc - HYNIC -TOC EDDA and 111In - DTPA-octreotide
18 Recruiting A Study of Pembrolizumab in Patients With Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: Pembrolizumab
19 Recruiting Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: Lenvatinib
20 Recruiting Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis
Condition: Neuroendocrine Tumors
Intervention: Other: Metastasized intestinal NET

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.